PIONEERING EXONEURAL MEDICINES
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Oct 2022)
What this means for you
This application is over — abandoned 10 Oct 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90280802
- Mark type
- Stylized text
- Filed
- 27 Oct 2020
- Published for opposition
- 11 Jan 2022
- Abandoned
- 10 Oct 2022
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology and pharmaceuticals
Owner
- Cygnal Therapeutics, Inc., Cambridge, MA, US
- Cygnal Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 11 Oct 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Oct 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Mar 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Jan 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Jan 2022 — PUBLISHED FOR OPPOSITION
- 22 Dec 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Dec 2021 — ASSIGNED TO LIE
- 08 Dec 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Dec 2021 — ASSIGNED TO EXAMINER
- 30 Sept 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Sept 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Sept 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Mar 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2021 — NON-FINAL ACTION E-MAILED
- 31 Mar 2021 — NON-FINAL ACTION WRITTEN